1834 Investment Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-31,899
Closed -$6.08M 430
2018
Q3
$6.08M Buy
31,899
+31,849
+63,698% +$5.85M 0.89% 49
2018
Q2
$8K Hold
50
﹤0.01% 384
2018
Q1
$8K Hold
50
﹤0.01% 401
2017
Q4
$8K Buy
+50
New +$8.97K ﹤0.01% 422
2016
Q3
Sell
-9,164
Closed -$2.12M 172
2016
Q2
$2.12M Buy
+9,164
New +$2.11M 0.46% 61

Other funds holding AGN

1834 Investment Advisors's AGN Position: Q4 2018 in Review

1834 Investment Advisors sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 31,899 shares — an estimated $6.08M sold.

1834 Investment Advisors first reported a position in AGN in Q2 2016 and held it in 5 quarters. The position peaked at $6.08M in Q3 2018. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • 1834 Investment Advisors reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • 1834 Investment Advisors sold 31,899 Allergan plc shares in Q4 2018, an estimated $6.08M.
  • 1834 Investment Advisors first reported a position in Allergan plc in Q2 2016 and held it in 5 quarters.
  • 1834 Investment Advisors's Allergan plc position peaked at $6.08M in Q3 2018.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on 1834 Investment Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.